| __timestamp | Halozyme Therapeutics, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 52602000 | 3068000000 |
| Thursday, January 1, 2015 | 105812000 | 3027000000 |
| Friday, January 1, 2016 | 113485000 | 3222000000 |
| Sunday, January 1, 2017 | 285461000 | 3532000000 |
| Monday, January 1, 2018 | 141726000 | 3914000000 |
| Tuesday, January 1, 2019 | 150446000 | 4268000000 |
| Wednesday, January 1, 2020 | 224227000 | 4618000000 |
| Friday, January 1, 2021 | 361897000 | 5473000000 |
| Saturday, January 1, 2022 | 520812000 | 5626000000 |
| Sunday, January 1, 2023 | 636892000 | 5834000000 |
| Monday, January 1, 2024 | 6537000000 |
Infusing magic into the data realm
In the ever-evolving landscape of the pharmaceutical industry, Zoetis Inc. and Halozyme Therapeutics, Inc. have carved distinct paths over the past decade. From 2014 to 2023, Zoetis Inc. consistently demonstrated robust growth, with its gross profit soaring by nearly 90%, peaking at approximately $5.8 billion in 2023. This impressive trajectory underscores Zoetis's dominance in the animal health sector.
Conversely, Halozyme Therapeutics, Inc. has shown a remarkable upward trend, with its gross profit increasing by over 1,100% during the same period. Starting from a modest base, Halozyme's strategic innovations have propelled it to a gross profit of around $637 million in 2023.
This comparison highlights the diverse strategies and market positions of these two companies, offering valuable insights into their financial health and future potential.
Gross Profit Trends Compared: Johnson & Johnson vs Halozyme Therapeutics, Inc.
Gross Profit Analysis: Comparing Novartis AG and Zoetis Inc.
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Halozyme Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Halozyme Therapeutics, Inc.
Key Insights on Gross Profit: Zoetis Inc. vs Lantheus Holdings, Inc.
Gross Profit Analysis: Comparing Zoetis Inc. and Vericel Corporation
Gross Profit Trends Compared: Zoetis Inc. vs Taro Pharmaceutical Industries Ltd.
Zoetis Inc. vs Amphastar Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Biogen Inc. vs Halozyme Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Walgreens Boots Alliance, Inc. and Halozyme Therapeutics, Inc. Trends
Halozyme Therapeutics, Inc. and MorphoSys AG: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Halozyme Therapeutics, Inc. vs Bausch Health Companies Inc.